Figure 1.
Clonal hematopoiesis of indeterminate potential (CHIP) is a common age-related condition that represents a clonal pre-phase of hematologic neoplasms with low progression risk, as well as a major risk factor for cardiovascular disease. Next-generation sequencing (NGS) is used to detect and monitor clonal hematopoiesis.
